Search

everythinglearnresearchcommunity

for

Search:↓

BB4CMU rice bran oil may help treat hair loss and gray hair.

Bimatoprost is more effective than sweet almond oil for enhancing eyebrow growth.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

COVID-19 might cause gray hair to regain color.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Women are more likely to have long-term post-COVID symptoms than men.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

AGA might indicate higher risk for severe COVID-19.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

There's no significant genetic link between male pattern baldness and COVID-19.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

Mothers with lower stress during pregnancy but higher stress after birth had infants with lower development scores.

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

COVID-19 worsens urinary symptoms in men with benign prostatic hyperplasia, requiring careful treatment management.